Generalists need education on HF treatment
Heart failure
Generalists need education on HF treatment
Feb 7, 2012 14:00 EST
A unique study trying to drill down into why cardiologists seem to gain better outcomes than generalists when treating heart failure has identified a number of reasons that this is the case. But generalists—who treat the majority of HF—have to deal with older and sicker patients, confounding the issue. The authors hope the work will act as a catalyst to improve HF care.
Acute Coronary Syndromes
TRA 2°P: Vorapaxar meets end point but ups bleeding
Feb 7, 2012 12:20 EST
In its second phase 3 trial, Merck's novel antiplatelet agent reduced ischemic events but increased bleeding, including ICH. Results looked more promising in patients without a history of stroke.
Arrhythmia/EP
ICDs charged with sex discrimination: Women get fewer shocks
Feb 6, 2012 17:00 EST
Differences in appropriate-therapy and device-related complication rates in a prospective study question (once again) whether women and men should have the same ICD-eligibility criteria.
heartbriefs
heartbriefs
View all »

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Life and times of leading cardiologists with Rob Califf. Guest: Martin Leon
Editorial series
Life and times of leading cardiologists with Rob Califf. Guest: Martin Leon
1 COMMENT - Feb 7, 2012 09:00 EST
Dr Martin Leon talks about his decision to become a doctor at age six, how the death of his mother led him to interventional cardiology, and the genesis of the internationally renowned TCT meetings.
Antithrombotic therapies in ACS: An update from Europe
Editorial series
Antithrombotic therapies in ACS: An update from Europe
Jan 30, 2012 10:30 EST
Drs Jean-Pierre Bassand, Peter Clemmensen, and Jean-Philippe Collet review the latest data on antithrombotic therapies in ACS. Hear the European perspective on antiplatelet therapy, anticoagulation agents, and anticoagulants in the setting of primary PCI.
European perspectives on CRT therapy: An update for 2012
Editorial series
European perspectives on CRT therapy: An update for 2012
Jan 24, 2012 08:59 EST
Drs Cecilia Linde and Pierre Bordachar discuss the latest trial findings in CRT and the implications for research, practice, and patient outcomes in 2012.
Salt, hypertension, and prevention
Editorial series
Salt, hypertension, and prevention
8 COMMENTS - Jan 16, 2012 08:24 EST
Dr Bob Harrington talks to Drs Michael Alderman and Lawrence Appel about the challenges in understanding the role of salt in cardiovascular disease and why it is such a controversial topic.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Topolog by Dr Eric Topol
Topolog
Talking about a (healthcare) revolution: The digital age ushers in precision medicine
4 comments
Jan 25, 2012 11:25 EST
The digital age is revolutionizing the healthcare paradigm by replacing an archaic and wasteful population-based model with precision medicine.
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Brain/Kidney/Peripheral
For stroke risk, look for novel lipid/lipoprotein biomarkers
Feb 8, 2012 11:15 EST
Interventional/Surgery
Braile Biomédica launches transapical valve
Feb 7, 2012 16:30 EST
Medscape Medical News
Wake-up stroke patients may still benefit from thrombolysis
Feb 7, 2012 15:00 EST
Acute Coronary Syndromes
SWITCH III: Bivalirudin is as safe as heparin after fondaparinux in PCI patients
Feb 7, 2012 12:30 EST
Acute Coronary Syndromes
CTO, even in non-infarct-related artery, bodes ill in NSTEMI patients
Feb 7, 2012 09:45 EST
Lipid/Metabolic
Fitness and fatness independently linked with CVD risk factors
1 COMMENT - Feb 6, 2012 16:00 EST
Acute Coronary Syndromes
MI-shock proposal is cold comfort: Hypothermia might boost survival
Feb 6, 2012 16:00 EST
Brain/Kidney/Peripheral
KEEP: Focus on CKD patients with highest SBP
Feb 6, 2012 12:30 EST
Acute Coronary Syndromes
"Irrational" choices stall adoption of new antiplatelets
5 COMMENTS - Feb 6, 2012 09:15 EST
Medscape Medical News
No recurrent stroke prevention seen with clopidogrel plus aspirin
1 COMMENT - Feb 3, 2012 17:15 EST
Heart failure
Heart failure linked to loss of brain gray matter
Feb 3, 2012 16:15 EST
Most popular
  1. The flap over flavonoids
  2. "Valve-on-a-stick" transaortic TAVI offers alternative to transfemoral route
  3. Dr Robert Harrington leaves DCRI for Stanford University
  4. Cardiologists accused of defrauding Medicare by performing unnecessary cardiac procedures
  5. Contaminated cardiac drugs kill more than 100 in Pakistan
  6. No recurrent stroke prevention seen with clopidogrel plus aspirin
  7. "Tetherless" power-transmission technology could radically change LVAD therapy
  8. PLATO: PPI analysis "raises flag" but should not change practice
  9. Don't routinely replace spent ICDs: Proposal
  10. Aspirin as effective as warfarin in heart failure: WARCEF
View all news »
  1. What is happening in this tracing?
  2. What is the mechanism of aortic insufficiency for this 60-year-old man with a murmur?
  3. Heart attack deaths plummet in three EU nations
  4. Statins reduce cardiovascular events and all-cause mortality in women: Meta-analysis
  5. The flap over flavonoids
  6. Cardiologists accused of defrauding Medicare by performing unnecessary cardiac procedures
  7. "Irrational" choices stall adoption of new antiplatelets
  8. Iodine allergy
  9. US bleeding ADRs higher with dabigatran than warfarin
  10. Not Your Mother's Cath Lab
View all discussions »
Membership is free!
Like us on FacebookFollow us on Twitter
Inside Themes
Interventional/Surgery
ACUTE MI
Featured program
Approach to Improve Strategies to Reduce Risk for SCA Post-PCI
RELEASE DATE: Sep 20, 2011
Arrhythmia/EP
AF Stroke Prevention
Featured program
A New Era in the Management of AF: An Update on Oral Anticoagulation
RELEASE DATE: Sep 27, 2011
Interventional/Surgery
Advances in Arterial Access
Featured program
Making Same-Day Discharge After PCI a Reality: What You Need to Know
RELEASE DATE: Dec 19, 2011
Acute Coronary Syndromes
Antiplatelet Therapies
Featured program
Testing the Trialist: Addressing the Platelet in ACS and PCI
RELEASE DATE: Sep 21, 2011
Interventional/Surgery
Cathether Based Therapies
Featured program
Minimizing Stroke in TAVI
RELEASE DATE: Oct 12, 2011
Hypertension
Comprehensive PAH Management
Featured program
Management of PAH: When and How to Use IV Agents
RELEASE DATE: Aug 31, 2011
Interventional/Surgery
Drug-Eluting Stents
Featured program
The Complex Case of...NSTEMI in a Patient With Diabetes and Multivessel Disease
RELEASE DATE: Sep 26, 2011
Arrhythmia/EP
Emerging Approaches to HF
Featured program
Optimal Implementation of Evidence-Based HF Therapies on Mortality
RELEASE DATE: Sep 07, 2011
Lipid/Metabolic
Residual Risk Management
Featured program
HDL-C in the Spotlight: Modulating CETP to Reduce Cardiovascular Risk
RELEASE DATE: Sep 19, 2011
Hypertension
Resistant Hypertension
Featured program
Bridging Treatment Gaps to Better Manage Resistant Hypertension
RELEASE DATE: Dec 09, 2011
Clinical cardiology
Stable Ischemic Heart Disease
Featured program
Tips for Enhancing Medical Therapy in Patients With SIDH
RELEASE DATE: May 17, 2011
Interventional/Surgery
Stents, Structure and Stenosis
Featured program
How Novel Stent Technology Improves Patient Outcomes
RELEASE DATE: Jun 28, 2011
Interventional Cardiology Live Case Study Series
Interventional Cardiology Live Case Study Series
On February 21, 2012, join Drs. Sharma, Kini and Mehta as they present advanced interventional techniques used in complex cases LIVE from Mt. Sinai's Cath Lab
View archived programs
Press center
Latest cardiology-related press releases and communications from industry
Poll
What will be the biggest story of 2012?
New anticoagulants
Renal nerve ablation
HDL-raising therapies
Transcatheter valves
Wireless/Remote monitoring

See: Biggest cardiology stories of 2011
Vote
Also on theheart.org
All about dronedarone, from ATHENA to PALLAS
Editorial series
All about dronedarone, from ATHENA to PALLAS
1 COMMENT - Jan 6, 2012 07:30 EST
Join Drs Melissa Walton-Shirley and Anne Gillis as they discuss the latest data on dronedarone and the impact for clinicians treating AF patients with significant structural heart disease.
AHA 2011 trials to treatments: ATLAS ACS2, TRACER, and MI FREEE
The Cardiology Show
AHA 2011 trials to treatments: ATLAS ACS2, TRACER, and MI FREEE
3 COMMENTS - Nov 16, 2011 14:30 EST
Dr Valentin Fuster sits down with Drs William Boden, John Chapman, Keith Fox, Anne Gillis, Jessica Mega, and Clyde Yancy to tackle the brave new world of antithrombotics and to ask whether academics have left the real world, and their patients, behind.